Fabry disease (FD), a rare X-linked multiorgan disorder, develops based on >900 known mutations in the alpha-galactosidase A (GLA) gene coding for the homonymous GLA enzyme [1], which is part of the cellular lipid metabolism. This evidence concerns the gene GLA and Fabry disease.